Sign in →

Test Code AGSER Aspergillus Galactomannan EIA (Serum)

Important Note

STOP!

 

Blood must be collected in a gold-top (SST) tube.  Centrifuge and send specimen in this original collection tube.  Do not aliquot or open tube.

Clinical Indications

The Platelia™ Aspergillus Galactomannan EIA is a test,
when used in conjunction with other diagnostic procedures, such as
microbiological culture, histological examination of biopsy
specimens, and radiographic evidence that can be used to aid in the
diagnosis of Invasive Aspergillosis. Twice weekly monitoring of
neutropenic patients is often recommended in the peer-reviewed
literature to obtain maximum diagnostic utility of the assay.

Additional Test Codes

Epic Order Name: ASPERGILLUS (GALACTOMANNAN) AG (aka AGSER)
Sunquest Order Code: AGSER
Epic Px Code: LAB2081

Specimen Collection Type

Preferred: Gold
(cannot be shared with other tests)

Minimum Collection Volume

1.0 mL

Reference Range

The reference range is an index of <0.5 numerical index
values will be reported.
Patients with an index of ≥0.5 are considered to be positive
for galactomannan antigen.
Patients with an index of <0.5 are considered to be negative for
galactomannan antigen.
Specimens testing positive will be retested to confirm the positive
result.
•A reference Index Value of <0.5 has been shown to be
appropriate for both serum and bronchial lavage specimen types.

Critical Value

N/A

Interpretation

For maximum sensitivity, the test should be performed at least
twice weekly during neutropenia. The exact frequency of testing in
non-hospitalized patients with chronic graft-versus-host-disease
(CGVHD) would depend upon the degree of immunosuppression. The test
should be used in conjunction with other diagnostic procedures.

Two consecutive positive results are required for classification as
true positive, thus it is recommended that a follow-up specimen be
submitted from the patient upon receipt of the initial positive
result; ideally prior to initiation of anti fungal therapy to
achieve maximum specificity.

Rejection Criteria

Specimens that have been poured off (due to the potential for
environmental contamination of the sample that can lead to false
positive results, the gold top tubes should be centrifuged and sent
to the lab with the cap intact).  Lipemic, icteric, or
hemolyzed specimens, specimens that have been stored at ambient
temperature, specimens received in trap containers, specimens
beyond their acceptable length of time from collection as listed in
the Specimen Stability.

Specimen Availability for Add-on Testing

This test cannot be added on.

Specimen Stability

Frozen (preferred): 14 days
Refrigerated: 5 days
Ambient: Unacceptable

Day(s) Performed

Monday through Saturday

Performing Lab- Department

TUKHS-BH-Mail Outs

CPT Code

87305

LOINC Code

44357-2

Test Alias

Platelia Aspergillus Galactomannan EIA (Serum)

Additional Information / Notes

To avoid potential contamination, we send the original tube,
centrifuged but not aliquotted. Therefore this tube cannot be
shared with other tests.
Assay Limitations

A negative test result cannot rule out the diagnosis of Invasive
Aspergillosis. Patients at risk for Invasive Aspergillosis should
be tested twice per week.

If a positive result is obtained, a second specimen should be
collected and sent for testing immediately.

The performance of the test has not been evaluated with neonatal
specimens.

This test may exhibit reduced detection in patients with chronic
granulomatous disease and Job’s Syndrome.

The concomitant use of mold-active, anti fungal therapy in some
patients with Invasive Aspergillosis may result in reduced
sensitivity of the test.

There are reports in the literature of positive galactomannan test
results in patients receiving piperacillin/tazobactam,therefore,
results in these patients should be interpreted with caution and
confirmed with other diagnostic methods.
There are reports in the literature of positive galactomannan test
results in patients with intestinal mucositis caused by
chemotherapy and irradiation, which allows for extra absorption of
dietary galactomannan.

False-positive Galactomannan results have been shown in patients
receiving Plasmalyte for intravenous hydration or if Plasmalyte is
used for BAL collection.